MymaA.18344.a
Malate synthase G
CENTER ID:
MymaA.18344.a
ORGANISM:
Mycobacterium marinum ATCC BAA-535 / M
ASSOCIATED DISEASE:
Cutaneous ulcerations, deep abscesses
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
False
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
IIIC
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
MymaA.18344.a.B1.GE40295
Full length(MymaA.18344.a)
info
1
731
MymaA.18344.a.B1.GE40295
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
NOTE: Effective as of September 1, 2026, SSGCID will no longer ship physical clone glycerols. SSGCID will provide amino acid and nucleotide sequences for any clones ordered, which the ordering party
can then use to order the clone from a third-party clone manufacturer.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
MymaA.18344.a.B1.PS38275
Full length(MymaA.18344.a)
info
1
731
PS38275
Structures
6AXE
DEPOSITED: 9/6/2017
DETERMINATION: XRay
CLONE: MymaA.18344.a.B1.GE40295
PROTEIN: MymaA.18344.a.B1.PS38275
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MTDRVSAGNL RVARVLYDFV NNEALPGTDI DQDSFWAGVD KVVTDLTPQN QDLLKTRDDL QAQIDKWHRH RVIEPLDPQA YREFLTEIGY LLPAPEDFTI TTSGVDDEIT TTAGPQLVVP ILNARFALNA ANARWGSLYD ALYGTDVISE SDGAEKGRGY NKVRGDKVIA YARQFLDDSV PLAGASYTDA TGFKVEDGQL VVSLADTSAA LADPGQFAGY TGTAENPKSI LLANHGLHIE ILIDPESQIG ATDGAGVKDV ILESAITTIM DFEDSVAAVD ADDKVLGYRN WLGLNRGDLS EDVTKDDKTF TRVLNTDRTY TAPHGGELTL PGRSLLFVRN VGHLMTNDAI VSDAEGAEGA PVFEGIMDAL FTGLIAIHGL RSTDANGLLT NSRTGSIYIV KPKMHGPAEV AFTCELFSRV EDVLGLPQGT MKVGIMDEER RTTLNLKACI KAAADRVVFI NTGFLDRTGD EIHTSMEAGP MIRKGAMKNT AWIKAYEDAN VDTGLAAGFS GKAQIGKGMW AMTELMADMV EQKIAQPKAG ATTAWVPSPT AATLHAMHYH KVDVFAVQKE LQGKTRTSVD ELLTIPLAKE LAWAPEEIRE EVDNNCQSIL GYVVRWIDQG VGCSKVPDIH NVALMEDRAT LRISSQLLAN WLRHGVITSE DARASLERMA PLVDKQNAGD PEYHAMAPNF DDSIAFLAAQ DLILSGAQQP NGYTEPILHR RRRELKARAG A
NT Sequence
ATGACGGATC GCGTGTCGGC GGGGAATTTG CGCGTCGCTC GGGTGCTCTA CGACTTCGTA AACAACGAGG CCCTGCCCGG CACCGACATC GACCAGGACA GCTTCTGGGC GGGCGTGGAC AAGGTGGTCA CCGACCTCAC CCCGCAGAAC CAGGATTTGC TGAAGACTCG CGATGATCTG CAGGCCCAGA TCGACAAGTG GCATCGCCAC CGGGTGATCG AGCCGTTGGA CCCGCAGGCC TACCGCGAGT TCCTCACCGA GATCGGGTAC CTGCTGCCGG CACCCGAGGA CTTCACCATC ACCACCTCCG GGGTTGACGA CGAGATCACC ACGACCGCCG GCCCGCAGCT GGTGGTGCCG ATCCTCAACG CGCGGTTCGC CCTCAACGCT GCCAACGCCC GCTGGGGCTC GCTCTACGAC GCCTTGTACG GCACCGACGT CATCTCCGAA AGCGACGGCG CCGAAAAGGG CCGGGGCTAC AACAAGGTCC GTGGTGACAA GGTAATCGCC TACGCGCGCC AGTTCCTCGA CGACAGCGTG CCGCTGGCGG GGGCCTCCTA CACCGATGCC ACAGGCTTCA AGGTGGAAGA CGGACAGCTG GTGGTGTCGC TGGCGGACAC GTCCGCAGCG CTGGCCGATC CCGGCCAGTT CGCCGGCTAC ACCGGCACCG CCGAGAACCC TAAGTCGATC CTGCTGGCCA ATCACGGGCT GCACATCGAG ATCCTGATCG ACCCCGAGTC GCAGATCGGT GCCACCGACG GCGCCGGCGT CAAGGACGTG ATCCTGGAGT CCGCCATCAC CACGATCATG GACTTCGAGG ACTCGGTGGC CGCGGTCGAC GCTGACGACA AGGTGCTGGG CTATCGGAAC TGGCTCGGAC TGAACCGGGG CGATCTGTCC GAGGACGTCA CCAAGGACGA CAAGACCTTC ACCCGGGTGC TCAACACCGA CCGCACCTAC ACCGCCCCGC ACGGTGGTGA GCTGACCTTG CCCGGCCGCA GCCTGTTGTT CGTCCGCAAC GTGGGCCACC TGATGACCAA CGACGCCATC GTTTCGGACG CGGAAGGCGC CGAGGGCGCC CCGGTGTTCG AGGGCATCAT GGATGCGCTG TTCACCGGCC TGATCGCCAT CCACGGTCTG CGAAGCACCG ATGCCAACGG GCTGTTGACC AACAGCCGCA CGGGCTCCAT CTACATCGTC AAGCCCAAGA TGCACGGTCC CGCCGAGGTG GCGTTCACCT GTGAATTGTT CAGCCGCGTC GAGGACGTGC TGGGGTTGCC GCAGGGGACC ATGAAGGTCG GCATCATGGA CGAAGAGCGA CGTACCACGC TCAACTTGAA GGCATGCATC AAGGCGGCCG CCGACCGGGT GGTGTTTATC AACACCGGCT TCCTGGACCG CACCGGTGAT GAGATCCACA CCTCGATGGA AGCCGGCCCG ATGATCCGCA AGGGCGCGAT GAAGAACACG GCGTGGATCA AGGCCTACGA GGACGCCAAC GTCGACACCG GGCTCGCCGC CGGCTTCTCC GGTAAGGCGC AGATCGGCAA GGGCATGTGG GCGATGACCG AACTGATGGC CGACATGGTG GAGCAGAAGA TTGCCCAGCC GAAGGCCGGC GCGACCACCG CGTGGGTGCC ATCGCCCACC GCGGCCACCC TGCACGCGAT GCACTATCAC AAGGTGGATG TCTTTGCCGT GCAGAAGGAG CTGCAGGGCA AGACCCGCAC CAGCGTTGAC GAATTGCTGA CCATTCCGTT GGCCAAGGAA CTGGCCTGGG CGCCCGAGGA GATCCGCGAA GAGGTCGACA ACAACTGCCA GTCCATCCTC GGTTACGTGG TGCGTTGGAT CGACCAGGGC GTCGGCTGTT CGAAGGTTCC CGACATCCAC AACGTGGCCC TCATGGAGGA CCGCGCCACC CTGCGGATTT CCAGCCAGTT GCTGGCCAAC TGGCTACGGC ATGGCGTGAT CACCAGCGAG GATGCGCGGG CTAGCCTCGA GCGCATGGCA CCGCTGGTGG ACAAGCAGAA CGCCGGAGAT CCCGAATACC ACGCGATGGC ACCCAATTTC GACGACAGCA TCGCATTCCT GGCGGCCCAG GATCTGATCT TGTCGGGGGC ACAGCAGCCC AACGGATACA CGGAGCCGAT CCTGCACCGC CGTCGTCGTG AATTGAAGGC ACGCGCTGGT GCC
Details for MymaA.18344.a.B1.GE40295
HARVESTED ON:
6/13/2016
SEQUENCED ON:
6/16/2016
EXPECTED MW:
80kDa
OBSERVED MW:
80kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
High Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
data unavailable
SEQUENCING RESULT:
PERCENT IDENTITY:
100
PERCENT COVERAGE:
84
Details for MymaA.18344.a.B1.PS38275
PURIFICATION DATe:
5/9/2017
CONCENTRATION:
47.3mg/ml
OBSERVED MW:
80kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
4
VIAL VOLUME:
200µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
84